Keywords: schering-plough, cutting, jobs, ireland, result, falling, sales
Schering-Plough cutting jobs in Ireland
Article | 19 January 2004
As a result of falling sales of its Peg-Intron (peginterferon alfa 2b) and as part of previously-announced $200 million cost-cutting restructuring ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
